Arca Biopharma reported $-5675000 in EBITDA for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amgen AMGN:US USD 3.5B 62M
Arca Biopharma ABIO:US USD -5675000 1.58M
Biogen BIIB:US USD 992.8M 82.9M
Brainstorm Cell Therapeutics BCLI:US USD -6771000 749K
Bristol Myers Squibb BMY:US USD 5.32B 456M
Cytokinetics CYTK:US USD -107033000 97.57M
Cytrx CYTR:US USD -1290880 691.86K
Daiichi Sankyo 4568:JP JPY 76.31B 27.06B
Gilead Sciences GILD:US USD 3.28B 731M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Laboratory Of America LH:US USD 678.7M 50.7M
Myriad Genetics MYGN:US USD -31900000 27.1M
Otsuka Holdings 4578:JP JPY 77.06B 7.4B
Pfizer PFE:US USD 10.52B 2.78B
United Therapeutics UTHR:US USD 327.2M 112.7M